Specialized, integrative treatment for long-standing eating disorders: early insights and implications
Abstract
Background: Eating disorders (EDs) are severe and multifaceted psychiatric conditions. Despite advancements in treatment modalities, a substantial gap persists in evidence-based interventions specifically designed for individuals with enduring EDs.
Objective: To address this critical clinical need, a specialized residential unit dedicated exclusively to the care of adults with long-standing EDs was launched within the Catalan Public Health System in January 2024. This study introduces the unit's innovative therapeutic model and presents preliminary outcomes related to patient satisfaction, body mass index (BMI), and quality of life.
Method: This preliminary investigation included 18 participants diagnosed with anorexia nervosa (AN) or other specified feeding or eating disorders (OSFED/AN), according to DSM-5 criteria. Each participant underwent a structured clinical interview and completed a comprehensive battery of quantitative and qualitative assessments. These measures evaluated clinical status, psychopathology, personality traits, quality of life, and satisfaction with the treatment received over an average stay of 3-4 months.
Results: Participants had a mean illness duration exceeding 12 years and had previously undergone at least three treatment attempts that did not result in sustained clinical or functional improvement. Despite having 22% high educational attainment, 94% were unemployed. High rates of psychiatric comorbidity were observed. Post-treatment analyses…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.